
|Articles|September 1, 2003
The Head of its Class
Author(s)Jennifer Clark
San Francisco - Oral terbinafine (Lamisil) is the most cost-effective treatment for toenail onychomycosis as compared to other available agents, according to the results of an economic evaluation.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














